1,510
Views
964
CrossRef citations to date
0
Altmetric
Review Article

Phyto-oestrogens and Western Diseases

&
Pages 95-120 | Published online: 30 Oct 2013

References

  • Dunn JE. Cancer epidemiology in populations of the United States, with emphasis on Hawaii and California, and Japan. Cancer Res 1975; 35: 3240–5.
  • Trowell HC, Burkitt DP. Western Diseases: Their Emergence and Prevention. London: Edward Arnold Ltd, 1981.
  • Reddy BS, Cohen LA (eds). Diet, nutrition, and cancer: a critical evaluation. In: Macronutrients and Cancer. Volume I. Boca Raton, FL: CRC Press, 1986.
  • Reddy BS, Cohen LA (eds). Diet, nutrition and cancer: a critical evaluation. In: Micronutrients, Nonutritive Dietary Factors, and Cancer. Volume II. Boca Raton, FL: CRC Press, 1986.
  • Rose DP, Boyar AP, Wynder EL. International comparison of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 58: 2363–71.
  • Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 50 (Suppl 201): 3–23.
  • Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 1995; 6: 181–3.
  • Griffiths K, Adlercreutz H, Boyle P, Denis L, Nicholson RI, Morton MS. Nutrition and Cancer. Oxford: ISIS Medical Media, 1996.
  • Adlercreutz H, Fotsis T, Heikkinen R, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancef 1982; 2: 1295–9.
  • Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the 'fiber hypothesis'. Gastroenterology 1984; 86: 761–4.
  • Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103: 103–12.
  • Bannwart C, Fotsis T, Heikkinen R, Adlercreutz H. Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin Chim Acta 1984; 136: 165–72.
  • Setchell KDR, Borriello SP, Hulme P, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984; 40: 569–78.
  • Adlercreutz H, Musey PI, Fotsis T, et al. Identification of lignans and phytoestrogens in urine of chimpanzees. Clin Chim Acta 1986; 158: 147–54.
  • Adlercreutz H. Lignans and phytoestrogens. Possible preventive role in cancer. In: Horwitz C, Rozen P, eds. Progress in Diet and Nutrition. Basel: S. Karger, 1988: 165–76.
  • Setchell KDR, Adlercreutz H. Mammalian lignans, and phyto-oestrogens. Recent studies on their formation, metabolism, and biological role in health and disease. In: Rowland I, ed. Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988: 315–45.
  • Adlercreutz H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis. Proc Soc Exp Biol Med (in press).
  • Setchell KDR, Adlercreutz H. The excretion of two new phenolic compounds (180/442 and 180/410) during the human menstrual cycle and in pregnancy. J Steroid Biochem 1979; 11: xv-xvi.
  • Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and in animal species. Nature 1980; 287: 740–2.
  • Setchell KDR, Lawson AM, Axelson M, Adlercreutz H. The excretion of two new phenolic compounds during the menstrual cycle and in pregnancy. In: Adlercreutz H, Bulbrook R, van der Molen H, Vermeulen A, Sciarra F, eds. Endocrinological Cancer, Ovarian Function and Disease. Int Congr Series No. 515. Amsterdam: Excerpta Medica, 1980: 297–315.
  • Price KR, Fenwick GR. Naturally occurring oestrogens in foods - a review. Food Addict Contam 1985; 2: 73–106.
  • Lindner H. Occurrence of anabolic agents in plants and their importance. Environ Qual Saf 1976; 5: 151–8.
  • Messina M, Messina V, Setchell K. The Simple Soybean and Your Health. Garden City Park, NY: Avery Publishing Group, 1994.
  • Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk - a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113–31.
  • Adlercreutz CHT, Goldin BR, Gorbach SL, et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995; 125: 757S–70S.
  • Obermeyer WR, Warner C, Casey RE, Musser S. Flaxseed lignans. Isolation, metabolism and biological effects. FASEB J 1993; 7, Abstract 4985.
  • Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of
  • Adlercreutz H, Fotsis T, Bannwart C, et al. Assay of lignans and phytoestrogens in urine of women and in cow milk by GC/MS (SIM). In: Todd JFJ, ed. Advances in Mass Spectrometry-85. Proceedings of the 10th International Mass Spectrometry Conference. Chichester: John Wiley, 1986:661-2. Hutchins AM, Lampe JW, Martini MC, Campbell DR, Slavin JL. Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Diet Assoc 1995; 95: 769–74.
  • Kirkman LM, Lampe JW, Campbell DR, Martini MC, Slavin JL. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer 1995; 24: 1–12.
  • Nilsson M, Âman P, Harkónen H, Bach Knudsen KE, Mazur W, Adlercreutz H. Content of nutrients and lignans in roller milled fractions of rye. J Sci Food Agr 1997; 73: 143–8.
  • Walz E. Isoflavon- and saponin-glucoside in So/a hispida. Justus LiebigsAnn Chem 1931; 498: 118–55 (in German).
  • Walz E. Isoflavon- and saponin-glucoside in Soja hispida. Justus Liebigs Ann Chem 1931; 498: 118–55 (in German).
  • Walter ED. Genistin (an isoflavone glucoside) and its aglucone, genistein, from soybeans. J Am Chem Soc 1941; 63: 3273–6.
  • Eldridge A, Kwolek WF. Soybean isoflavones: effect of environment and variety on composition. J Agr Food Chem 1983; 31: 394–6.
  • Naim M, Gestetner B, Kirson I, Birk Y, Bondi A. A new isoflavone from soy beans. Phytochemistry 1973; 22: 237–9.
  • Murphy PA. Phytoestrogen content of processed soy-bean products. Food Techn 1982; 60–4.
  • Franke AA, Custer U, Cerna CM, Narala KK. Quantita-tion of phytoestrogens in legumes by HPLC. J Agr Food Chem 1994; 42: 1905–13.
  • Yokotsuka T. Soy sauce biochemistry. Adv Food Res 1986; 30: 195–329.
  • Pettersson H, Kiessling K-H. Liquid chromatographic determination of the plant coumestrol and isoflavones in animal feed. J Assoc Off Anal Chem 1984; 67: 503–6.
  • Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein, and their beta-glycoslde conjugates -antitumor isoflavones in soybean foods from American and Asian diets. J Agr Food Chem 1993; 41: 1961–7.
  • Coward L, Barnes NC, Setchell KDR, Barnes S. Genis-tein, daidzein, and their beta-glycoside conjugates - antitumor isoflavones in soybean foods from American and Asian diets. J Agr Food Chem 1993; 41: 1961–7.
  • Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phyto-estrogens. J Am Diet Assoc 1994; 94: 739–43.
  • Wang HJ, Murphy PA. lsoflavone content in commercial soybean foods. J Agr Food Chem 1994; 42: 1666–73.
  • Rosenblum ER, Van Thiel DH, Campbell IM, Eagon PK, Gavaler JS. Separation and identification of phytoestro-genic compounds isolated from bourbon. Alcohol Alcohol 1987; Suppl. 1: 551–5.
  • Rosenblum ER, Campbell IM, Vanthiel DH, Gavaler JS. Isolation and identification of phytoestrogens from beer. Alcohol Clin Exp Res 1992; 16: 843–5.
  • Lapcik L, Hampl R, Al-Maharik N, Salakka A, Wähälä K, Adlercreutz H. A novel radioimmunoassay for daidzein. Steroids (in press).
  • Stitch SR, Toumba JK, Groen MB, et al. Excretion, isola-tion and structure of a phenolic constituent of female urine. Nature 1980; 287: 738–40.
  • Setchell KDR, Bull R, Adlercreutz H. Steroid excretion during the reproductive cycle and in pregnancy of the vervet monkey (Ceropithecus aethiopus pygerethus). J Steroid Biochem 1980; 12: 375–84.
  • Bannwart C, Adlercreutz H, Fotsis T, Wãhãlã K, Hase T, Brunow G. Identification of O-desmethylangolensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan anterolactone, in human urine. Finn Chem Lett 1984; 120–5.
  • Bannwart C, Adlercreutz H, Wãhãlã K, Brunow G, Hase T. Detection and identification of the plant lignans lari-ciresinol, isolariciresinol and secoisolariciresinol in human urine. Clin Chim Acta 1989; 180: 293–302.
  • Setchell KDR, Lawson AM, McLaughlin LM, Patel S, Kirk DN, Axelson M. Measurement of enterolactone and enterodiol, the first mammalian lignans, using stable isotope dilution and gas chromatography mass spectrometry. Biomed Mass Spectrom 1983; 10: 227–35.
  • Adlercreutz H, Fotsis T, Lampe J, et al. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas-chromatography mass-spectrometry. Scand J Clin Lab Invest 1993; 53:5–18.
  • Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209–10.
  • Adlercreutz H, Fotsis T, Watanabe S, et al. Determina-tion of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prey 1994; 18: 259–71.
  • Adlercreutz H, Fotsis T, Kurzer MS, Wâhãlã K, MikeIfi T, Hase T. Isotope dilution gas chromatographic mass spectrometric method for the determination of unconju-gated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal Biochem 1995; 225: 101–8.
  • Finlay EMH, Wilson DW, Adlercreutz H, Griffiths K. The identification and measurement of 'phyto-oestrogens' in human saliva, plasma, breast aspirate or cyst fluid, and prostatic fluid using gas chromatography-mass spectro-metry. J Endocrinol 1991; 129 (Suppl), Abstract 49.
  • Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak oestro-gen equol [7-hydroxy-3-(4'-hydroxyphenyl) chroman] in human urine. Biochem J 1982; 201: 353–7.
  • Bannwart C, Adlercreutz H, Fotsis T, Wãhãlã K, Hase T, Brunow G. Identification of isoflavonic phytoestrogens, and of lignans in human urine and in cow milk by GC/MS. In: Todd JFJ, ed. Advances in Mass Spectrometry-85. Proceedings of the 10th International Mass Spectrometry Conference. Chichester: John Wiley, 1986: 661–2.
  • Bannwart C, Adlercreutz H, Wähälä K, Brunow G, Hase T. Identification of the isoflavonic phytoestrogens formo-nonetin and dihydrodaidzein in human urine. International Symposium on Applied Mass Spectrometry in the Health Sciences, Abstracts. Barcelona: Fira de Barcelona, Spain, 1987: 169.
  • Bannwart C, Adlercreutz H, WähdIA K, et al. Identifica-tion of the phytoestrogen 3',7-dihydroxyisoflavan, an isomer of equol, in human urine and cow milk. Biomed Environ Mass Spectrom 1988; 17: 1–6.
  • Adlercreutz H, Fotsis T, Bannwart C, WAWA K, Brunow G, Hase T. Isotope dilution gas chromato-graphic-mass spectrometric method for the determina-tion of lignans and isoflavonoids in human urine, including identification of genistein. Clin Chim Acta 1991; 199: 263–78.
  • Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993; 223: 9–22.
  • Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995; 54: 167–84.
  • Müller H-M, Hofmann J, Mayr U. Stoffwechsel und Wirkung von Phytoõstrogenen beim Tier. Ubers Tierernàhrg 1989; 17: 47–84.
  • Adlercreutz H, Mousavi Y, Loukovaara M, Hãmãlãinen E. Lignans, isoflavones, sex hormone metabolism and breast cancer. In: Hochberg R, Naftolin F, eds. The New Biology of Steroid Hormones. Serono Symposia Publications from Raven Press Vol. 74. New York: Raven Press, 1991.
  • Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972; 52: 299–310.
  • Setchell KDR, Lawson AM, Borriello SP, et al. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 1981 ; 2: 4–7.
  • Axelson M, Setchell KDR. The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 1981 ; 123: 337–42.
  • Setchell KDR, Lawson AM, Borriello SP, Adlercreutz H, Axe!son M. Formation of lignans by intestinal microflora. In: Malt RA, Williamson RCN, eds. Colonic Carcino-genesis: Falk Symposium 3/. Lancaster: MTP Press, 1982: 93–7.
  • Borriello SP, Setchell KDR, Axe!son M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J App! Bacteriol 1985; 58: 37–43.
  • Pettersson D, Aman P, Knudsen KEB, et al. Intake of rye bread by ileostomists increases ileal excretion of fiber polysaccharide components and organic acids but does not increase plasma or urine lignans and isoflavonoids. J Nutr 1996; 126: 1594–600.
  • Adlercreutz H, Martin F, Jfirvenpää P. Steroid absorption and enterohepatic recycling. Contraception 1979; 20: 201–24.
  • Adlercreutz H, Martin F. Review. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 1980; 13: 231–44.
  • Adlercreutz H, Järvenpää P. Assay of estrogens in human feces. J Steroid Biochem 1982; 17: 639–45.
  • Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, ¡n urine of women on various habitual diets. J Steroid Biochem 1986; 25:791–7.
  • Adlercreutz H, Fotsis T, Heikkinen R, et al. Diet and urinary excretion of lignans in female subjects. Med Bidl 1981; 59: 259–61.
  • Adlercreutz H, Höckerstedt K, Bannwart C, et al. Effect of dietary components, including lignans and phytoestro-gens, on enterohepatic circulation and liver metabolism of estrogens, and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27:1135–44.
  • Adlercreutz H, Höckerstedt K, Bannwart C, Hãmãlâinen E, Fotsis T, Bloigu S. Association between dietary fiber, urinary excretion of lignans, and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: Bresciani F, King RJB, Lippman ME, Raynaud J-P, eds. Progress in Cancer Research and Therapy, Vol. 35: Hormones and Cancer 3. New York: Raven Press, 1988: 409–12.
  • Lampe JW, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994; 60: 122–8.
  • Kurzer MS, Lampe JW, Martinit MC, Adlercreutz H. Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Cancer Epidemiol Biomarkers Prey 1995; 4: 353–8.
  • Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HHS, Thompson LU. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed.
  • Batterman TJ, Hart NK, Lamberton JA. Metabolism of oestrogenic isoflavones in sheep. Nature 1965; 4983: 509.
  • Braden AWH, Hart NK, Lamberton JA. The oestrogenic activity of and metabolism of certain isoflavones in sheep. Aust J AgrRes 1967; 18: 335–48.
  • Nilsson A, Hill JL, Davies HL. An in vitro study of formo nonetin and biochanin A in rumen fluid from sheep. Biochim BiophysActa 1967; 148: 92–8.
  • Shutt DA, Weston RH, Hogan JR Quantitative aspects of phyto-oestrogen metabolism in sheep fed on subterranean clover {Trifolium subterraneum cultivar clare) or red clover {Trifolium pratense). Austr J Agr Res 1970; 21: 713–22.
  • Braden AWH, Thaun RI, Shutt DA. Comparison of plasma phyto-oestrogen levels in sheep and cattle after feeding on fresh clover. Austr J Agr Res 1971; 22: 663–70.
  • Hackett AM. The metabolism of flavonoid compounds in mammals. In: Cody V, Middleton CV Jr, Harborne JB, eds. Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships. New York: Alan R. Liss, Inc., 1986:125–40.
  • Bokkenheuser VD, Winter J. Hydrolysis of flavonoids by human intestinal bacteria. In: Cody V, Middleton CV Jr, Harborne JB, eds. Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medicinal Proper-ties. New York: Alan R. Liss, Inc, 1988: 143–5.
  • Bokkenheuser VD, Shackleton CHL, Winter J. Hydro-lysis of dietary flavonoid glycosides by strains of intestinal Bacterioides from humans. Biochem J 1987; 248: 933–56.
  • Axelson M, Sjövall J, Gustafsson BE, Setchell KDR. Soya - a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 1984; 102: 49–56.
  • Adlercreutz H, Honjo H, Higashi A, et al. Urinary excre-tion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am J Gun Nutr 1991; 54: 1093–100.
  • Musey PI, Adlercreutz H, Gould KG, et al. Effect of diet on lignans and isoflavonoid phytoestrogens in chimpan-zees. Life Sc, 1995; 57: 655–64.
  • Noteboom WD, Gorski J. Estrogenic effect of genlstein and coumestrol diacetate. Endocrinology 1963; 73: 736–9.
  • Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phyto-estrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978; 103: 1860–7.
  • Newsome FE, Kitts WD. Action of phyto-estrogens coumestrol and genistein on cytosolic and nuclear oestra-dio1-1711 receptors in immature rat uterus. Anim Reprod Sci 1980; 3: 233–45.
  • Tang BY, Adams NR. Effect of equol on oestrogen recep-tors and on synthesis of DNA and protein in the immature rat uterus. J Endocrinol 1980; 85: 291–7.
  • Jordan VC, Koch R, Bain RR. Prolactin synthesis by cultured rat pituitary cells: an assay to study estrogens, antiestrogens and their metabolites in vitro. In: McLachlan JA, ed. Estrogens in the Environment II. Influences on Development. New York: Elsevier, 1985: 221–34.
  • Setchell KDR, Gosselin SJ, Welsh MB, et al. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987; 93: 225–33.
  • Gavaler JS, Galvao-Teles A, Monteiro E, Van Thiel DH, Rosenblum E. Clinical responses to the administration of bourbon phytoestrogens to normal postmenopausal women. Hepatology 1991; 14: 87A.
  • Van Thiel DH, Galvaoteles A, Monteiro E, Rosenblum E, Gavaler JS. The phytoestrogens present in de-ethano.
  • Whitten PL, Naftolin F. Dietary estrogens - a biologically active background for estrogen action. In: Hochberg RB, Naftolin F, eds. New Biology of Steroid Hormones. New York: Raven Press, 1991: 155–67.
  • Makela S, Pylkkanen L, Santti R, Adiercreutz H. Role of plant estrogens in normal and estrogen-related altered growth of the mouse prostate. EURO FOOD TOX III. Proceedings of the Interdisciplinary Conference on Effects of Food on the Immune and Hormonal Systems. CH-8603 Schwerzenbach, Switzerland: Institute of Toxicology, Swiss Federal Institute of Technology and University of Zurich, 1991: 135–9.
  • Makela S, Santti R, Salo L, McLachlan JA. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect 1995; 103: 123–7.
  • Nwannenna Al, Lundh TJO, Madej A, Fredriksson G, Bjornhag G. Clinical changes in ovariectomized ewes exposed to phytoestrogens and 17/3-estradiol implants. Proc Soc Exp Biol Med 1995; 208: 92–7.
  • Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 1966; 34: 215–25.
  • Folman Y, Pope GS. Effect of norethisterone acetate, dimethylstilboestrol, genistein and coumestrol on uptake of Plljoestradiol by uterus, vagina and skeletal muscle of immature mice. J Endocrinol 1969; 44: 213–8.
  • Kitts WD, Newsome FE, Runeckles VC. The estrogenic and antiestrogenic effects of coumestrol and zearalanol on the immature rat uterus. Can J Anim Sci 1983; 63: 823–34.
  • Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoes-trogen equol. Breast Cancer Res Treat 1987; 10: 169–75.
  • Mikelii S, Davis VL, Tally WC, et al. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells Environ Health Perspect 1994; 102: 572–8.
  • Markaverich BM, Webb B, Densmore CL, Gregory RR. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect 1995; 103: 574–81.
  • >Adams NR. Organizational and activational effects of phytoestrogens on the reproductive tract of the ewe. Proc Soc Exp Biol Med 1995; 208: 87–91.
  • Perel E, Lindner HR. Dissociation of uterotrophic action from implantation-inducing activity in two non-steroidal oestrogens (coumestrol and genistein). J Reprod Fert 1970; 21: 171–5.
  • Whitten PL, Russell E, Naftolin F. Influence of phyto-estrogen diets on estradiol action in the rat uterus_ Steroids 1994; 59: 443–9.
  • Loukovaara M, Carson M, Palotie A, Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 1995; 60: 656–61.
  • Loukovaara M, Carson M, Adlercreutz H. Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro. Biochem Biophys Res Commun 1995; 206: 895–901.
  • Waters AP, Knowler JT. Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J Reprod Fertil 1982; 66: 379–81.
  • Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 1992; 41: 615–9.
  • Sathyamoorthy N, Wang TTY, Phang JM. Stimulation of pS2 expression by diet-derived compounds. Cancer Res 1994;54:957–61.
  • Adlercreutz H, Bannwart C, Wàhalã K, et al. Inhibition of human aromatase by mammalian lignans and isoflavo-noid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147–53.
  • Gansser D, Spiteller G. Aromatase inhibitors from urtica dioica roots. Planta Med 1995; 61: 138–40.
  • Kellis JT Jr, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984; 225: 1032–4.
  • Ibrahim A-R, Abul-Hajj YJ. Aromatase inhibition by flavo-noids. J Steroid Biochem Mol Biol 1990; 37: 257–60.
  • Campbell DR, Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 1993; 46: 381–8
  • Pelissero C, Lenczowski MJP, Chinzi D, Davailcuisset B, Sumpter JP, Fostier A. Effects of flavonoids on aroma-tase activity, an in vitro study. J Steroid Biochem Mol Biol 1996; 57: 215–23.
  • Wang CF, Makela T, Hase T, Adlercreutz H, Kurzer MS. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994; 50: 205–12.
  • Keung WM. Dietary estrogenic isoflavones are potent inhibitors of /1-hydroxysteroid dehydrogenase of P. testo-steronii. Biochem Biophys Res Commun 1995; 215: 1137–44.
  • Keung W-M. Biochemical studies of a new class of alcohol dehydrogenase inhibitors from Radix puerariae. Alcohol Clin Exp Res 1993; 17:1254–60.
  • McEvily AJ, Holmquist B, Auld DS, Vallee BL. 3/1-hydroxy-5/3-steroid dehydrogenase activity of human liver alcohol dehydrogenase is specific to gamma-subunits. Biochemistty 1988; 27: 4284–8.
  • Keung WM, Vallee BL. Daidzin - a potent, selective inhibitor of human mitochondrial aldehyde dehydro-genase. Proc Natl Acad Sci USA 1993; 90: 1247–51.
  • Evans BAJ, Griffiths K, Morton MS. Inhibition of 5a-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295–302.
  • Akiyama T, lshida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592–5.
  • Akiyama T, Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. In: Hunter T, Sefton BM, eds. Protein Phosphotylation, Pt B. San Diego: Academic Press Inc, 1991.
  • Ogawara H, Akiyama T, Watanabe S-I, Ito N, Kobori M, Seoda Y. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones. J Antibiot (Tokyo) 1989; XLI I: 340–3.
  • Uckun FM, Evans WE, Forsyth CJ, et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995; 267: 886–91.
  • Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988; 157: 183–9.
  • Markovits J, Linassier C, Fossé P, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989; 49: 5111–7.
  • Kondo K, Tsuneizumi K, Watanabe T, Oishi M. Induc-tion of in vitro differentiation of mouse embryonal carci-noma (F9) cells by inhibitors of topoisomerases. Cancer Res 1991; 51: 5398–404.
  • Constantinou A, Mehta R, Runyan C, Rao K, Vaughan A, Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 1995; 58: 217–25.
  • Huang JM, Nasr M, Kim YH, Matthews HR. Genistein inhibits protein histidine kinase. J Biol Chem 1992; 267: 15511–5.
  • Le Cam A. Natural tyrosine-kinase inhibitors. Pathol Biol (Paris) 1991;39:796–800.
  • Lehtola L, Lehvãslaiho H, Koskinen P, Alitalo K. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein. Acta Oncol 1992; 31: 147–50.
  • Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992; 41: 331–7.
  • Markaverich BM, Clark JH. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response. Endocrinology 1979; 105: 1458–62.
  • Markaverich BM, Upchurch S, Clark JH. Progesterone and dexamethasone antagonism of uterine growth: a role for a second nuclear binding site for estradiol in estrogen action. J Steroid Biochem 1981; 14: 125–32.
  • Markaverich BM, Roberts RR, Alejandro MA, Clark JH. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res 1984; 44:1515–9.
  • Markaverich BM, Gregory RR, Alejandro M-A, Clark JH, Johnson GA, Middleditch BS. Methyl p-hydroxy-phenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type II binding sites. J Biol Chem 1988; 263: 7203–10.
  • Markaverich BM, Schauweker TH, Gregory RR, et al. Nuclear type-II sites and malignant cell proliferation - inhibition by 2,6-bis-benzylidenecyclohexanones. Cancer Res 1992; 52: 2482–8.
  • Markaverich BM, Roberts RR, Alejandro M, Johnson GA, Middleditch BS, Clark JH. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibi-tion. J Steroid Biochem 1988; 30: 71–8.
  • Hammond GL. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab 1995; 6: 298–304.
  • Fortunati N, Fissore F, Fazzari A, et al. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase a. Endocrinology 1996; 137: 686–92.
  • Mousavi Y, Adlercreutz H. Genistein is an effective stimu-lator of SHBG production in Hep-G2 human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 301–4.
  • Loukovaara M, Carson M, Adlercreutz H. Regulation of sex hormone-binding globulin secretion and gene expres-sion by cycloheximide in vitro. J Steroid Biochem Mol Biol 1995; 54: 141–6.
  • Armstrong BK, Brown JB, Clarke HT, et al. Diet and reproductive hormones: a study of vegetarian and non-vegetarian postmenopausal women. J Natl Cancer lnst 1981; 67: 761–7.
  • Adlercreutz H, Himiliinen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989; 49: 433–42.
  • Shultz TD, Bonorden WR, Seaman WR. Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men. Nutr Res 1991; 11: 1089–100.
  • Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993; 77: 1215–9.
  • Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333–40.
  • Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1685–90.
  • Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 1995; 74: 587–601.
  • Loukovaara M, Carson M, Adiercreutz H. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocrinol Metab 1995; 80: 160–4.
  • Lipworth L, Adami HO, Trichopoulos D, Carlestrom K, Mantzoros C. Serum steroid hormone levels, sex hormone binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996; 7: 96–100.
  • Shutt DA. The effects of plant estrogens on animal repro-duction. Endeavour 1976; 35: 110–3.
  • Mathieson RA, Kitts WD. Binding of phytoestrogens and oestradio1-17/1 by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 1980; 85: 317–25.
  • Tang BY, Adams NR. Changes in oestradio1-17/1 binding in the hypothalami and pituitary glands of persistently infertile ewes previously exposed to oestrogenic sub-terranean clover: evidence of alterations to oestradiol receptors. J Endocrinol 1978; 78: 171–7.
  • Nettle JA, Kitts WD. Effects of phyto-estrogenic alfalfa consumption on plasma LH levels in cycling ewes. Anim Reprod Sci 1983; 6: 233–8.
  • Bindon BM, Adams NR, Piper LR. Effects of oestrogenic pasture on luteinizing hormone levels and the response to GnRH in female lambs. Anim Reprod Sci 1982; 5: 7–13.
  • Lu L-EW, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prey 1996; 5: 63–70.
  • Messina M. Isoflavone intakes by Japanese were overestimated. Am J Clin Nutr 1995; 62: 645.
  • Orcheson L, Rickard S, Seidl M, et al. Estrus cycle and organ changes in rats fed flaxseed, its mammalian lignan precursor or tamoxifen. FASEB J 1993; 7, Abstract 1686.
  • Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Nati Acad Sci USA 1993; 90: 2690–4.
  • Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavo-noid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 125: S790–7.
  • Pepper MS, Montesano R. Proteolytic balance and capil-lary morphogenesis. Cell Differ Dev 1990; 32: 319–28.
  • Montesano R, Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985; 42: 469–77.
  • Rastinejad F, Polverini PJ, Bouck NR Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56: 345–55.
  • Ullrich A, Schlesinger J. Signal transduction by recep-tors with tyrosine kinase activity. Cell 1990; 61: 203–12.
  • Linassier C, Pierre M, Le Pecq J-B, Pierre J. Mechan-isms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 1990; 39: 187–93.
  • Yamashita Y, Kawada S, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 1990; 39: 737–44.
  • Teicher BA, Holden SA, Ara G, Korbut T, Menon K. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma. Cancer Chemother Pharmacol 1996; 38: 169–77.
  • Rao CBS, ed. The Chemistry of Lignans. Waltair, India: Andhra University Press and Publications, 1978.
  • Markkanen T, Mãkinen ML, Maunuksela E, Himanen P. Podophyllotoxin lignans under experimental antiviral research. Drugs Exp Clin Res 1981; 7: 711–8.
  • Ayres DC, Loike JD. Lignans. Chemical, biological and clinical properties. In: Philllpson JD, Ayres DC, Baxter H, eds. Chemistry & Pharmacology of Natural Products. Cambridge: Cambridge University Press, 1990.
  • Eich E, Pertz H, Kaloga M, et al. (-)-Arctigenln as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J Med Chem 1996; 39: 86–95.
  • Krol W, Czuba ZP, Threadgill MD, Cunningham BDM, Pietsz G. Inhibition of nitric oxide (NO*) production In murine macrophages by flavones. Biochem Pharmacol 1995; 50: 1031–5.
  • Atluru D, Gudapaty S. Inhibition of bovine mononuclear cell proliferation, interleukin-2 synthesis, protein-tyrosine kinase and leukotriene-B(4) production by a protein-tyrosine kinase inhibitor, genistein. Vet Immunol Immuno-pathol 1993; 38: 113–22.
  • Atluru D, Gudapaty S, Odonnell MP, Woloschak GE. Inhibition of human mononuclear cell proliferation, inter-leukin synthesis, messenger RNA for IL-2, IL-6, and leuko-triene-B(4) synthesis by a lipoxygenase inhibitor. J Leukoc Biol 1993; 54: 269–74.
  • Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189–95.
  • Kliewer EV, Smith KR. Breast cancer mortality among immigrants in Australia and Canada. J Natl Cancer Inst 1995; 87:1154–61.
  • Kennedy AR. The evidence for soybean products as cancer preventive agents. J Nutr 1995; 125: S733–43.
  • Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer lnst 1991; 83: 541–6.
  • Adlercreutz H, Mousavi Y, Höckerstedt K. Diet and breast cancer. Acta Oncol 1992; 31: 175–81.
  • Rose DP. Dietary fiber, phytoestrogens, and breast cancer. Nutrition 1992; 8: 47–51.
  • Adlercreutz H. Lignans, isoflavonoids, sex hormones and hormone-dependent cancer. In: Görög S, ed. Advances in Steroid Analysis '93. Budapest: Akadémiai Kiadó, 1993: 511–29.
  • Adlercreutz H, Carson M, Mousawi Y, et al. Lignans and isoflavonoids of dietary origin and hormone-dependent cancer. In: Waldron KW, Johnson IT, Fenwick GR, eds. Food and Cancer Prevention: Chemical and Biological Aspects. Cambridge: The Royal Society of Chemistry, 1993: 349–52.
  • Rose DP. Diet, hormones and cancer. Annu Rev Public Health 1993; 14: 1–17.
  • Clarkson TB, Anthony MS, Hughes CL. Estrogenic soybean isoflavones and chronic disease - risks and benefits. Trends Endocrinol Metab 1995; 6:11–6.
  • Messina NI. Modern applications for an ancient bean: soybeans and the prevention and treatment of chronic disease. J Nutr 1995; 125: S567–9.
  • Hawrylewicz EJ, Zapata JJ, Blair WH. Soy and experi-mental cancer: animal studies. J Nutr 1995; 125: S698–708.
  • Wehling M. Nongenomic actions of steroid hormones. Trends Endocrinol Metab 1994; 5: 347–53.
  • Adlercreutz H. Effect of diet and exercise on hormones: implications for monitoring training in women. Clin J Sports Med 1991; 1: 149–53.
  • Barnes S, Peterson G, Grubbs C, Setchell K. Potential role of dietary isoflavones in the prevention of cancer. In: Jacobs MM, ed. Diet and Cancer: Markers, Prevention, and Treatment. New York: Plenum Press, 1994: 135–47.
  • Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 1995; Suppl22: 181–7.
  • Hirayama T. A large scale cohort study on cancer risk by diet - with special referrence to the risk reducing effects of green-yellow vegetable consumption. In: Hayashi Y, Nagao M, Sugimura T, eds. Diet, Nutrition and Cancer. Tokyo and trecht: Japan Sci Soc Press and VNU Sci Press, 1986:41–53.
  • Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197–200.
  • Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 1995; 71: 1353–8.
  • Adlercreutz H, Hamalàinen E, Gorbach S, Goldin B. Dietary phyto-oestrogens and the menopause in Japan. Lancer 1992; 339: 1233.
  • Goldin BR, Adlercreutz H, Gorbach SL, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986; 44: 945–53.
  • Shimizu H, Ross RK, Pike MC, Henderson BE. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 1990;62:451–3.
  • Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer 1990; 62: 631–6.
  • Bernstein L, Ross RK, Pike MC, Brown JB, Henderson BE. Hormone levels in older women; a study of post-menopausal breast cancer and healthy population controls. Br J Cancer 1990; 61: 298–302.
  • Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hãmãlãinen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 1994; 86: 1076–82.
  • Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190–7.
  • Willett WC, Hunter DJ, Stampfer MJ, et al. Dietary fat and fiber in relation to risk of breast cancer. JAMA 1992; 21: 2037–44.
  • Lubin F, Wax Y, Modan B. Role of fat, animal protein, and dietary fiber in breast cancer etiology: a case-control study. J Nat Cancer Inst 1986; 77: 605––12.
  • vant Veer P, Kolb CM, Verhoef P, et al. Dietary fiber, beta-carotene and breast cancer: results from a case-control study. Int J Cancer 1990; 45: 825–8.
  • Baghurst PA, Rohan TE. High-fiber diets and reduced risk of breast cancer. Int J Cancer 1994; 56: 173–6.
  • Adlercreutz H. Diet and sex hormone metabolism. In: Rowland IR, ed. Nutrition, Toxicity, and Cancer. Boca Raton, FL: CRC Press, 1991: 137–95.
  • Pryor M, Slattery ML, Robison LM, Egger M. Adoles-cent diet and breast cancer in Utah. Cancer Res 1989; 49: 2161–7.
  • Hughes RE. Dietary fibre and female repoductive physi-ology. In: Burley VJ, ed. Dietary Fibre Perspectives Reviews & Bibliography, Vol 2. London: John Libbey, 1990: 76 86.
  • de Ridder CM, Thijssen JHH, Van't Veer P, et al. Dietary habits, sexual maturation, and plasma hormones in pubertal girls - a longitudinal study. Am J Clin Nutr 1991; 54: 805–13.
  • Arts CJM, Govers CARL, Vandenberg H, Thijssen JHH. Effects of wheat bran and energy restriction on onset of puberty, cell proliferation and development of mammary tissue in female rats. Acta Endocrinol 1992; 126: 451–9.
  • Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 1991; 18: S11–7.
  • Adlercreutz H, Fotsis T, Hõckerstedt K, et al. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 1989; 34: 527–30.
  • Hautanen A, Sarna S, Pelkonen R, Adlercreutz H. Serum sex hormone-binding globulin, cardiovascular risk factors, and adrenal Cortisol responses to dexamethasone and corticotropin. Metabolism 1993; 42: 870–4.
  • Venturelli E, Coradini D, Gornati D, Secreto G. Growth stimulatory effect and metabolism of testosterone in MCF-7 human breast cancer cells. Int J Oncol 1996; 8: 687–92.
  • Berrino F, Muti P, Michell A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88: 291–6.
  • Barnes S, Grubbs C, Setchell KDR, Carlson J. Soy-beans inhibit mammary tumors in models of breast cancer. In: Pariza MW, Aeschbacher HU, Eton JS, Sato S, eds. Mutagens and Carcinogens in the Diet. New York: Wiley-Liss, Inc., 1990: 239 53.
  • Constantinou A, Thomas C, Mehta R, Runyan C, Moon R. The effect of genistein and daidzein on MNU-induced mammary tumours in rats. Proceedings of the Eighty-sixth Annual Meeting of the American Association for Cancer Research. Toronto, Ont., Canada, 1995: 115 (Abstr).
  • Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells - independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991; 179: 661–7.
  • Hoffman R. Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein. Biochem Biophys Res Commun 1995; 211: 600–6.
  • Monti E, Sinha BK. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines. Anti-cancer Res 1994; 14: 1221–6.
  • Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 1994; 30A: 1675–82.
  • Scholar EM, Toews ML. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett 1994; 87: 159–62.
  • Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 1996; 7: 1345–51.
  • Upadhyaya P, El-Bayoumy K. Effects of dietary soy protein isolate and genistein on the levels of 7,12-dimethyl-benz(a)anthracene (DMBA)-DNA binding in mammary glands of female DC rats. Proceedings of the Eighty-sixth Annual Meeting of the American Association for Cancer Research. Toronto, Ont., Canada, 1995: 597 (Abstr).
  • Serraino M, Thompson LU. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett 1991; 60: 135–42.
  • Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 1992; 17: 153–9.
  • Thompson LU, Rickard SE, Orcheson U, Seidl MM. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996; 17: 1373–6.
  • Thompson LU, Seidl MM, Rickard SE, Orcheson U, Fong HHS. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 1996; 26: 159–65.
  • Hirano T, Oka K, Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 1989; 64: 69–78.
  • Teraoka H, Ohmura Y, Tsukada K. The nuclear matrix from rat liver is capable of phosphorylating exogenous tyrosine-containing substrates. Blochem Int 1989; 18: 1203–10.
  • Reddy KB, Mangold GL, Tandon AK, et al. Inhibition of breast cancer cell growth In vitro by a tyrosine kinase inhibitor. Cancer Res 1992; 52: 3636–41.
  • Wei HC, Wei LH, Frenkel K, Bowen R, Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and In vivo by genistein. Nutr Cancer 1993; 20: 1–12.
  • Hawrylewicz EJ, Huang HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991; 121: 1693–8.
  • Lamartiniere CA, Moore J, Holland M, Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995; 208: 120–3.
  • Lamartiniere CA, Murrill W, Brown N. Chemoprevention of breast cancer with the soy component genistein. Proceedings of the Annual Meeting of the Eighty-sixth American Association for Cancer Research. Toronto, Ont., Canada, 1995: 592 (Abstr).
  • Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996; 17: 1451–7.
  • Girl AK, Lu LJW. Genetic damage and the inhibition of 7,12-dimethylbenz[alpha]anthracene-inducedgeneticdamage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett 1995; 95: 125–33.
  • Verdeal K, Brown RR, Rickardson T, Ryan DS. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthra-cene-induced rat mammary tumors. J Natl Cancer Inst 1980; 64: 285–90.
  • Wang WQ, Tanaka Y, Han ZK, Higuchi CM. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer 1995; 23: 131–40.
  • Ota K, Misu VA. A study on latent carcinoma of the prostate in Japanese. GANN 1958; 49 (Suppl): 283–4.
  • Breslow NE, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977; 20: 680–8.
  • Yatani R, Chigusa I, Akazaki K, Stemmerman GN, Welsh RA, Correa P. Geographic pathology of latent prostatic cancer. Int J Cancer 1982; 29: 611–6.
  • Adlercreutz H, Honjo H, Higashi A, et al. Lignan and phytoestrogen excretion in Japanese consuming tradi-tional diet. Scand J Clin Lab Invest 1988; 48 (Suppl 190): 190 (Abstr).
  • Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer 1989; 64: 598–604.
  • Severson RK, Nomura AMY, Grove JS, Stemmerman GN. A prospective study of demographics and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49: 1857–60.
  • Lindner HR. Study of the fate of phyto-oestrogens in the sheep by determination of isoflavones and coumestrol in the plasma and adipose tissue. Aust J Agr Res 1967; 18: 305–33.
  • Setchell KDR, Welsh MB. High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and
  • Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS, Ewing LL. Soy of dietary source plays a preventive role against pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 1992; 43: 557–64.
  • Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men - establishment of age-specific reference ranges. JAMA 1993; 270: 860–4.
  • Oesterling JE, Kumamoto Y, Tsukamoto T, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white man. Br J Urol 1995; 75: 347–53.
  • Mãkelã SI, Pylkkãnen LH, Santti RS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. JNufr1995; 125:437–45.
  • Peterson G, Barnes S. Genistein and biochanin-A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophos-phorylation. Prostate 1993; 22: 335–45.
  • Rokhlin OW, Cohen MB. Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors. Cancer Lett 1995; 98: 103–10.
  • Adlercreutz H, Miikelfi S, Pylkkänen L, et al. Dietary phytoestrogens and prostate cancer. Proc Am Assoc Cancer Res 1995; 36: 687 (Extended Abstr).
  • Furusato M, Wakui S, Sasaki H, Ito K, Ushigome S. Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 1994; 70: 1244–6.
  • Ross RK, Bernstein L, Lobo RA, et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and United States white and black males. Lancet 1992; 339: 887–9.
  • Coumailleau P, Poellinger L, Gustafsson J-A, Whitelaw ML. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J Biol Chem 1995; 270: 25291–300.
  • Poellinger L, Whitelaw M, McGuire J, et al. Regulation of dioxin receptor function by genistein and phytoanti-estrogens. Third International Conference on Phytoestrogens, Abstracts. Little Rock, AR: National Center for Toxicological Research, 1995.
  • Bergan R, Kyle E, Nguyen P, Trepel J, Ingui C, Neckers L. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin Exp Metastasis 1996; 14: 389–98.
  • Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963–6.
  • Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer - a prospective study in Hawaii. Epidemiology 1994; 5: 276 82.
  • Teppo L, Pukkala E, Hakama M, Hakulinen A, Herva A, Saxén E. Way of life and cancer incidence in Finland. Scand J Soc Med 1980; Suppl 19: 1–84.
  • Zhang J-X, Hallmans G, Landstriim M, et al. Soy and rye diets inhibit development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett 1997; 114: 1–2.
  • Winter ML, Bosland MC, Wade DR, Falvo RE, Nagamani M, Liehr JG. Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5a-dihydrotestosterone and 17/3-estradiol. Prostate 1995; 26: 325–33.
  • Shirai T, lmaida K, Masui T, et al. Effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl-
  • Leav I, Merk F, Kwan P, Ho SM. Androgen-supported estrogen-enhanced epithelial cell proliferation in the prostate of intact Noble rats. Prostate 1989; 15; 23–40.
  • Pylkkanen L, Santti R, Newbold R, McLachlan JA. Regional differences in the prostate of the neonatally estrogenized mouse. Prostate 1991; 18: 117–29.
  • Collins AT, Zhiming B, Gilmore K, Neal DE. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrinol 1994; 143: 269–77.
  • Veldscholte J, Berrevoets CA, Mulder E. Studies on the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 1994; 49: 341–6.
  • Castagnetta LA, Miceli MD, Sorci CMG, et al. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 1995; 136: 2309–19.
  • Rannikko S, Adlercreutz H. Plasma estradiol, free testos-terone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer. Prostate 1983; 4: 223–9.
  • Korpela JT, Adlercreutz H, Turunen MJ. Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and in patients with colorectal cancer. Scand J Gastroenterol 1988; 23: 277–83.
  • Watanabe S, Koessel S. Colon cancer: an approach from molecular epidemiology. J Epidemiol 1993; 3: 47–61.
  • Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 1983; 71: 703–9.
  • Conteas CN, Desai TK, Arlow FA. Relationship of hormones and growth factors to colon cancer. Gastro-enterol Clin North Am 1988; 17: 761–72.
  • Potter JD. Hormones and colon cancer. J Natl Cancer Inst 1995; 87: 1039–40.
  • Xu XM, Thomas ML. Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites. Endocrine 1995; 3: 661–5.
  • Singh S, Langman MJS. Oestrogen and colonic epithe-lial cell growth. Gut 1995; 37: 737–9.
  • Xu XM, Thomas ML. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 1994; 105: 197–201.
  • Calle EE, Miraclemcmahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 517–23.
  • Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and secondary primary malignancies. J Natl Cancer Inst 1995; 87: 645–51.
  • Thompson LU, Serraino M. Lignans in flaxseed and breast and colon carcinogenesis. Proc Flax Inst US. Fargo, ND, 1990: 30–5.
  • Serraino M, Thompson LU. Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Letters 1992; 63: 159–65.
  • Jenab M, Thompson LU. Influence of flaxseed and lignans on colon carcinogenesis. Proceedings of the Eighty-sixth Annual Meeting of the American Association for Cancer Research. Toronto, Ont., Canada, 1995: 114 (Abstr).
  • Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993; 53:5815–21.
  • Matsukawa Y, Marui N, Sakai T, et al. Genistein arrests cell cycle progression at G(2)-M. Cancer Res 1993; 53: 1328–31.
  • Helms JR, Gallaher DD. The effect of dietary soy protein isolate and genistein on the development of preneoplastic lesions (aberrant crypts) in rats. J Nutr 1994; 125 (Suppl): 802S.
  • Steele VE, Pereira MA, Sigman CC, Kelloff GJ. Cancer chemopreventlon agent development strategies for genistein. J Nutr 1995; 125: S713–6.
  • Heruth DP, Wetmore LA, Leyva A, Rothberg PG. Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel. J Cell Biochem 1995; 58: 83–94.
  • Kuo S-M, Summers R. Dietary flavonoids induce apoptosis of colon cancer cells. Proceedings of the Eighty-sixth Annual Meeting of the American Association for Cancer Research. Toronto, Ont., Canada, 1992; 33: 594 (Abstr).
  • Takeda Y, Nishio K, Morikage T, et al. Reversal of multi-drug resistance by genistein in non-P-glycoprotein mediated multidrug-resistant cell line (K562/TPA). Proceedings of the Eighty-sixth Annual Meeting of the American Association for Cancer Research. Toronto, Ont., Canada, 1992; 33: 476 (Abstr).
  • Takeda Y, Nishio K, Niitani H, Saijo N. Reversal of multi-drug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line. Int J Cancer 1994; 57: 229–39.
  • Versantvoort CHM, Schuurhuis GJ, Pinedo HM, et al. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 1993; 68: 939–46.
  • Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994; 48: 1129–36.
  • Schweigerer L, Christeleit K, Fleischmann G, et al. Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumours. Eur J Clin Invest 1992; 22: 260–4.
  • Anderson JW, Johnstone BM, Cooknewell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276–82.
  • Setchell KDR. Naturally occurring non-steroidal estro-gens of dietary origin. In: McLachlan JA, ed. Estrogens in the Environment II. Influences on Development. New York: Elsevier, 1985: 69–83.
  • Terpstra AHM, West CE, Fennis JTCM, et al. Hypocho-lesterolemic effect of dietary soy protein versus casein in Rhesus monkeys (Macaca mulatta). Am J Clin Nutr 1984; 39: 1–7.
  • Pratt DE, Birac PM. Source of antioxidant activity of soybeans and soy products. J Food Sci 1979; 44: 1720–2.
  • Wei HC, Bowen R, Cai OY, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995; 208: 124–30.
  • Ferrer MA, Barcelo AR. Control of the lignification in lupinus by genistein acting as superoxide scavenger and inhibitor of the peroxidase-catalyzed oxidation of coniferyl •alcohol. J Plant Physiol 1994; 144: 64–7.
  • Record IR, Dreosti 1E, McInerney JK. The antioxidant activity of genistein in vitro. J Nutr Biochem 1995; 6: 481–5.
  • Tikkanen M J, Wãhalá K, Ojala S, Vihma V, Adlercreutz H. Isoflavonoid phytoestrogens contained in human LDL after soy feeding protect from Cu2+-induced oxidation of LDL in vitro. 68th Scientific Sessions of the American Heart Association. Anaheim, CL, 1995 (Abstr).
  • Cai QY, Wei HC. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 1996; 25: 1–7.
  • Raines EW, Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr 1995; 125: S624–30.
  • Shimokado K, Yokota T, Umezawa K, Sasaguri T, Ogata J. Protein tyrosine kinase Inhibitors inhibit chemotaxis of vascular smooth muscle cells. Arterioscler Thromb 1994; 14:973–81.
  • Shimokado K, Umezawa K, Ogata J. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Exp Cell Res 1995; 220: 266–73.
  • Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993; 109: 612–7.
  • Honoré EK, Williams JK, Anthony MS, Clarkson TB. Effects of dietary soy isoflavones on coronary vasodilata-tion, and neointimal formation after iliac artery balloon injury, in atherosclerotic monkeys. Third International Conference on Phytoestrogens, Abstracts. Little Rock, AR: National Center for Toxicological Research, 1995.
  • Xiong ZG, Burnette E, Cheung DW. Modulation of Ca2+-activated K+ channel activity by tyrosine kinase inhibitors in vascular smooth muscle cell. Eur J Pharmacol Mol Pharmacol 1995; 290: 117–23.
  • Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126: 43–50.
  • Gooderham MJ, Adlercreutz H, Ojala ST, Wahala K, Holub BJ. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentra-tions, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 1996; 126: 2000–6.
  • Pietinen P, Rimm E, Korhonen P, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the ATBC study. Circulation 1996; 94: 2720–7.
  • Gaudette DC, Holub BJ. Effect of genistein, a tyrosine kinase inhibitor, on U46619-lnduced phospholnositide phosphorylation in human platelets. Biochem Biophys Res Commun 1990; 170: 238–42.
  • Dhar A, Paul AK, Shukla SD. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine. Mol Pharmacol 1990; 37: 519–25.
  • Asahi M, Yanagi S, Ohta S, et al. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Lett 1992; 309: 10–4.
  • Rendu F, Eldor A, Grelac F, et al. Inhibition of platelet activation by tyrosine kinase inhibitors. Biochem Pharmacol 1992; 44: 881–8.
  • Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 1991; 39: 475–80.
  • Furman MI, Grigoryev D, Bray PF, Dise KR, Gold-schmidt-Clermont PJ. Platelet tyrosine kinases and fibrinogen receptor activation. Circ Res 1994; 75: 172–80.
  • Sergeant P, Ferndale RW, Sage SO. The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca-2+ entry in human platelets. FEBS Lett 1993; 315: 242–6.
  • Ozaki Y, Yatomi Y, Jinnai Y, Kume S. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions - genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover. Biochem Pharmacol 1993; 46: 395–403.
  • Filipeanu CM, Brailoiu E, Huhurez G, Slatineanu S, Baltatu O, Branisteanu DD. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction. Eur J Pharmacol 1995; 281: 29–35.
  • DiSalvo J, Pfitzer G, Semenchuk LA. Protein tyrosine phosphorylation, cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 1994; 72: 1434–9.
  • Abebe W, Agrawal DK. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol 1995; 26: 153–9.
  • Steusloff A, Paul E, Semenchuk LA, Disalvo J, Pfitzer G. Modulation of Ca2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation. Arch Biochem Biophys 1995; 320: 236–42.
  • Gould EM, Rembold CM, Murphy RA. Genistein, a tyrosine kinase inhibitor, reduces Ca2+ mobilization in swine carotid media. Am J Physiol Cell Physiol 1995; 37: C1425–9.
  • Yang SG, Saifeddine M, Hollenberg MD. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor - urogastrone and other agonists in gastric smooth muscle. Can J Physiol Pharmacol 1992; 70: 85–93.
  • Yang SG, Saifeddine M, Laniyonu A, Hollenberg MD. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle - differential block-ade by indomethacin and tyrosine kinase inhibitors. J Pharmacol Exp Ther 1993; 264: 958–66.
  • Herrera MD, Marhuenda E, Gibson A. Effects of genis-tein, an isoflavone isolated from Genista-Tridentata, on isolated guinea-pig ileum and guinea-pig ileal myenteric plexus. Planta Med 1992; 58: 314–6.
  • Hatakeyama N, Wang 0, Goyal RK, Akbarali HI. Muscarinic suppression of ATP-sensitive K+ channel in rabbit esophageal smooth muscle. Am J Physiol Cell Physiol 1995; 37: C877–85.
  • Gokita T, Miyauchi Y, Uchida MK. Effects of tyrosine kinase inhibitor, genistein, and phosphotyrosine-phospha-tase inhibitor, orthvanadate, on Ca(2+)-free contraction of uterine smooth muscle of the rat. Gen Pharmacol 1994; 25: 1673–7.
  • Aharonovits 0, Zik M, Livne AA, Granot Y. Vasopressin elevation of Na+/H+ exchange is inhibited by genistein in human blood platelets. Biochim Biophys Acta 1992; 1112: 181–6.
  • Lock M. Contested meanings of the menopause. Lancet 1991; 337:1270–2.
  • Cline JM, Paschold JC, Anthony MS, Obasanjo 10, Adams MR. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 1996; 65:1031–5.
  • Brzezinski A, Adlercreutz H, Shaoul R, Shmueli A, Reosler A, Schenker JG. Phytoestrogen-rich diet: a possible alternative for hormone replacement therapy. Meeting of the North American Menopause Society. Chicago, IL, 1996 (Abstr).
  • Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause J North Am Menopause Soc (in press).
  • Anderson JJ, Ambrose WW, Garner SC. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomised rat models. J Nutr 1995; 125: 799S (Abstr).
  • Tsutsumi N. Effect of coumestrol on bone metabolism in organ culture. Biol Pharm Bull 1995; 18: 1012–5.
  • Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996; 61: 629–37.
  • Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996; 126: 161–7.
  • Tang GWK. The climacteric of Chinese factory workers. Maturitas 1994; 19: 177–82.
  • WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994; 843: 11–3.
  • Nakamura T, Turner CH, Yoshikawa T, et al. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 1994; 9: 1071–6.
  • Tsunenari T, Yamada S, Kawakatsu M, Negishi H, Tsutsumi M. Menopause-related changes in bone mineral density in Japanese women: a longitudinal study on lumbar spine and proximal femur. Calcif Tissue Int 1995; 56: 5–10.
  • Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis - xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993; 101: 372–7.
  • Safe SH. Environmental and dietary estrogens and human health: is there a problem. Environ Health Perspect 1995; 103: 346–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.